| Overview upon miR-21 in lung cancer: focus on NSCLC C Bica-Pop, R Cojocneanu-Petric, L Magdo, L Raduly, D Gulei, ... Cellular and Molecular Life Sciences 75, 3539-3551, 2018 | 210 | 2018 |
| Clinical and pathological implications of miRNA in bladder cancer C Braicu, R Cojocneanu-Petric, S Chira, A Truta, A Floares, B Petrut, ... International journal of nanomedicine, 791-800, 2015 | 113 | 2015 |
| MicroRNAs as regulators of apoptosis mechanisms in cancer V Pileczki, R Cojocneanu-Petric, M Maralani, IB Neagoe, R Sandulescu Clujul Medical 89 (1), 50, 2016 | 104 | 2016 |
| Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ... J Gastrointestin Liver Dis 24 (4), 435-443, 2015 | 99 | 2015 |
| Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers R Cojocneanu Petric, C Braicu, L Raduly, O Zanoaga, N Dragos, ... OncoTargets and therapy, 2053-2066, 2015 | 96 | 2015 |
| The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression D Gulei, L Magdo, A Jurj, L Raduly, R Cojocneanu-Petric, A Moldovan, ... Cell Death & Disease 9 (2), 66, 2018 | 86 | 2018 |
| Implications of dietary ω‑3 and ω‑6 polyunsaturated fatty acids in breast cancer O Zanoaga, A Jurj, L Raduly, R Cojocneanu‑Petric, E Fuentes‑Mattei, ... Experimental and therapeutic medicine 15 (2), 1167-1176, 2018 | 84 | 2018 |
| A looking-glass of non-coding RNAs in oral cancer AI Irimie, C Braicu, L Sonea, AA Zimta, R Cojocneanu-Petric, K Tonchev, ... International journal of molecular sciences 18 (12), 2620, 2017 | 60 | 2017 |
| Understanding the role of non-coding RNAs in bladder cancer: from dark matter to valuable therapeutic targets C Pop-Bica, D Gulei, R Cojocneanu-Petric, C Braicu, B Petrut, ... International journal of molecular sciences 18 (7), 1514, 2017 | 57 | 2017 |
| MiR-181 family-specific behavior in different cancers: a meta-analysis view C Pop-Bica, S Pintea, R Cojocneanu-Petric, G Del Sal, S Piazza, ZH Wu, ... Cancer and Metastasis Reviews 37, 17-32, 2018 | 54 | 2018 |
| Inhibitory effect of CAPE and kaempferol in colon cancer cell lines—possible implications in new therapeutic strategies L Budisan, D Gulei, A Jurj, C Braicu, O Zanoaga, R Cojocneanu, L Pop, ... International journal of molecular sciences 20 (5), 1199, 2019 | 53 | 2019 |
| Role of key micronutrients from nutrigenetic and nutrigenomic perspectives in cancer prevention AI Irimie, C Braicu, S Pasca, L Magdo, D Gulei, R Cojocneanu, C Ciocan, ... Medicina 55 (6), 283, 2019 | 52 | 2019 |
| Aberrant miRNAs expressed in HER-2 negative breast cancers patient C Braicu, L Raduly, G Morar-Bolba, R Cojocneanu, A Jurj, LA Pop, ... Journal of Experimental & Clinical Cancer Research 37, 1-16, 2018 | 51 | 2018 |
| Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics AI Irimie, C Braicu, R Cojocneanu-Petric, I Berindan-Neagoe, ... Acta Odontologica Scandinavica 73 (3), 161-168, 2015 | 51 | 2015 |
| Plasma and tissue specific miRNA expression pattern and functional analysis associated to colorectal cancer patients R Cojocneanu, C Braicu, L Raduly, A Jurj, O Zanoaga, L Magdo, A Irimie, ... Cancers 12 (4), 843, 2020 | 47 | 2020 |
| miR‐181a/b therapy in lung cancer: reality or myth? C Braicu, D Gulei, R Cojocneanu, L Raduly, A Jurj, E Knutsen, GA Calin, ... Molecular oncology 13 (1), 9-25, 2019 | 45 | 2019 |
| Exosomes—Small Players, Big Sound D Gulei, AI Irimie, R Cojocneanu-Petric, JL Schultze, I Berindan-Neagoe Bioconjugate Chemistry 29 (3), 635-648, 2018 | 43 | 2018 |
| Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression C Braicu, R Buiga, R Cojocneanu, M Buse, L Raduly, LA Pop, S Chira, ... Journal of Experimental & Clinical Cancer Research 38, 1-17, 2019 | 41 | 2019 |
| The relevance of mass spectrometry analysis for personalized medicine through its successful application in cancer “Omics” CA Ciocan-Cartita, A Jurj, M Buse, D Gulei, C Braicu, L Raduly, ... International Journal of Molecular Sciences 20 (10), 2576, 2019 | 37 | 2019 |
| Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model C Braicu, V Pileczki, L Pop, RC Petric, S Chira, E Pointiere, ... PLoS One 10 (4), e0120936, 2015 | 33 | 2015 |
